Wendy S. Arnold - Jul 5, 2022 Form 4 Insider Report for Frequency Therapeutics, Inc. (FREQ)

Role: Chief People Officer
Signature: /s/ James P. Abely, Attorney-in-Fact for Wendy S. Arnold
Stock symbol: FREQ
Transactions as of: Jul 5, 2022
Transactions value $: -$8,570
Form type: 4
Date filed: 7/7/2022, 04:49 PM
Previous filing: Feb 23, 2022
Next filing: Aug 19, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FREQ	Common Stock	Options Exercise		+15K	+126.86%		26.8K	Jul 5, 2022	Direct	F1
transaction	FREQ	Common Stock	Sale	-$8.57K	-5.64K	-21.02%	$1.52	21.2K	Jul 6, 2022	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FREQ	Restricted Stock Unit	Options Exercise		-15K	-100%		0	Jul 5, 2022	Common Stock	15K		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2	Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units and does not represent discretionary trades by the Reporting Person.
F3	This transaction was executed in multiple trades through a broker-dealer at prices ranging from $1.48 to $1.56. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
F4	The restricted stock units will vest as to 50% on February 14, 2022 and 50% on July 4, 2022.